Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

Polycystic Ovary Syndrome or PCOS affects millions of women in the United States. There is currently no standard treatment for it. Weight loss drugs l ...

Three studies presented today at the Society of NeuroInterventional Surgery’s (SNIS) 22nd Annual Meeting discussed whether ...

Ozempic, a drug known for its physical health benefits, is now gaining recognition for its effectiveness in treating ...

Some adults using weight-loss drugs like Mounjaro have complained no longer having the stomach for alcohol is one of the side effects of the jab.

As the global obesity medication market skyrockets, South Korean pharmaceuticals are rushing to develop national obesity ...

Key Points Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street.However, the company ...

A new study has found that older adults and women taking the weight-loss drug semaglutide may lose more muscle than others, ...

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...

Weight loss drugs, like Ozempic, can help prevent stroke and reduce brain injury related complications, three separate ...

A study reveals potentially fatal side effects of GLP-1 drugs, that people are using to lose weight. It’s well known that ...

Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.